GRIFFON PHARMACEUTICALS
GRIFFON Pharmaceuticals is a biopharma company located in Montréal, Canada and Lausanne, Switzerland developing a new bifunctional peptide growth hormone releasing factor (GRF) and vasoactive intestinal peptide (VIP) analog. The company aims to develop GP119 in several indications with significant unmet needs. The company’s lead indication, LD-HIV, is commonly seen in patients with HIV with an approximate prevalence of 200,000 patients in the US.
GRIFFON PHARMACEUTICALS
Industry:
Biopharma Biotechnology
Founded:
2015-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.griffonpharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
Bicara Therapeutics
Bicara Therapeutics is developing a pipeline of bifunctional antibodies that exploit the recent advances in immuno-oncology.
Biopharmaceutical Research Company
Biopharmaceutical Research Company develops active pharmaceutical ingredients for plant therapeutics.
Promedior
Promedior is a biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases.
Founder
Official Site Inspections
http://www.griffonpharma.com
- Host name: 20.107.62.166.host.secureserver.net
- IP address: 166.62.107.20
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
